The Melanoma Nursing Initiative – Home › Forums › Targeted therapy › Dosing and administration › New BRAF/MEK inhibitors coming to market › Reply To: New BRAF/MEK inhibitors coming to market
September 30, 2018 at 7:02 pm
#4898
Any one else transition patients from tag/mek or zelb/cobi over to braf/mek-tovi?
So far the paients that we transitioned are all doing quite well. there are 2 patients who have had stroing GI toxicities & flu like sx within a month of starting tx who required drug holiday & dose reduction after 2 attempts to restart full dose & they are doing better on the reduced dose.